Skip to Content

AlzChem Group AG Akt. nach Kapitalherabsetzung ACT

Morningstar Rating
€52.40 +1.60 (3.15%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ACT is trading at a 583% premium.
Price
€50.99
Fair Value
€19.19
Uncertainty
High
1-Star Price
€27.78
5-Star Price
€78.56
Economic Moat
Wllkf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ACT is a good fit for your portfolio.

Trading Information

Previous Close Price
€50.80
Day Range
€51.0052.40
52-Week Range
€13.0052.40
Bid/Ask
€0.00 / €0.00
Market Cap
€533.24 Mil
Volume/Avg
390 / 10,867

Key Statistics

Price/Earnings (Normalized)
12.38
Price/Sales
0.96
Dividend Yield (Trailing)
2.36%
Dividend Yield (Forward)
2.36%
Total Yield
2.36%

Company Profile

AlzChem Group AG is an international chemical company. Its reportable segments are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.
Sector
Basic Materials
Industry
Specialty Chemicals
Stock Style Box
Small Core
Total Number of Employees
1,689

Comparables

Valuation

Metric
ACT
LXS
4369
Price/Earnings (Normalized)
12.3862.1352.21
Price/Book Value
2.920.484.35
Price/Sales
0.960.3410.60
Price/Cash Flow
5.4020.8245.85
Price/Earnings
ACT
LXS
4369

Financial Strength

Metric
ACT
LXS
4369
Quick Ratio
1.511.203.08
Current Ratio
2.522.484.56
Interest Coverage
8.47−13.12133.46
Quick Ratio
ACT
LXS
4369

Profitability

Metric
ACT
LXS
4369
Return on Assets (Normalized)
9.09%−0.48%9.51%
Return on Equity (Normalized)
24.69%−1.04%11.34%
Return on Invested Capital (Normalized)
23.24%0.11%10.53%
Return on Assets
ACT
LXS
4369
See how this stock stacks up to its competitors with Morningstar Investor

Specialty Chemicals Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Linde PLC
LIN
TbkpnpyKbzz$213.8 Bil
Sherwin-Williams Co
SHW
WxpvnzjkmWmvv$81.6 Bil
Ecolab Inc
ECL
ZqbkfqlmzThck$69.4 Bil
Air Products & Chemicals Inc
APD
RwspmrwtSfsp$58.4 Bil
DuPont de Nemours Inc
DD
GtcymbgmLtdbt$33.3 Bil
LyondellBasell Industries NV Class A
LYB
FfmpxjxZhkqb$31.6 Bil
PPG Industries Inc
PPG
YzprpymgDqbprk$29.9 Bil
International Flavors & Fragrances Inc
IFF
WlpwdvjhxKgk$24.4 Bil
Eastman Chemical Co
EMN
KhwflxtcPvnptgv$11.4 Bil
Sociedad Quimica Y Minera De Chile SA ADR
SQM
WvstwsqZhrvc$11.2 Bil

Sponsor Center